Risk stratification in heart failure with mild reduced ejection fraction

Heart failure with mid-range ejection fraction represents a heterogeneous and relatively young heart failure category accounting for nearly 20–30% of the overall heart failure population. Due to its complex phenotype, a reliable clinical picture of heart failure with mid-range ejection fraction patients as well as a definite risk stratification are still relevant unsolved issues. In such a context, there is growing interest in a comprehensive functional assessment by means of a cardiopulmonary exercise test, yet considered a cornerstone in the clinical management of patients with heart failure and reduced ejection fraction. Indeed, the cardiopulmonary exercise test has also been found to be particularly useful in the heart failure with mid-range ejection fraction category, several cardiopulmonary exercise test-derived parameters being associated with a poor outcome. In particular, a recent contribution by the metabolic exercise combined with cardiac and kidney indexes research group showed an independent association between the peak oxygen uptake and pure cardiovascular mortality in a large cohort of recovered heart failure with mid-range ejection fraction patients. Contextually, the same study supplied an easy approach to identify a high-risk heart failure with mid-range ejection fraction subset by using a combination of peak oxygen uptake and ventilatory efficiency cut-off values, namely 55% of the maximum predicted and 31, respectively. Thus, looking at the above-mentioned promising results and waiting for specific trials, it is reasonable to consider cardiopulmonary exercise test assessment as part of the heart failure with mid-range ejection fraction work-up in order to identify those patients with an unfavourable functional profile who probably deserve a close clinical follow-up and, probably, more aggressive therapeutic strategies.

[1]  G. Parati,et al.  CARDIOVASCULAR DEATH RISK IN RECOVERED MID-RANGE EJECTION FRACTION HEART FAILURE: INSIGHTS FROM CARDIOPULMONARY EXERCISE TEST. , 2020, Journal of cardiac failure.

[2]  G. Parati,et al.  Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction , 2020, ESC heart failure.

[3]  G. Parati,et al.  Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction , 2019, European journal of heart failure.

[4]  Thomas Thum,et al.  The continuous heart failure spectrum: moving beyond an ejection fraction classification. , 2019, European heart journal.

[5]  C. Cannon,et al.  Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry® , 2019, ESC heart failure.

[6]  A. Mebazaa,et al.  Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction , 2019, Journal of the American Heart Association.

[7]  M. Cho,et al.  Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries , 2018, Journal of the American Heart Association.

[8]  D. Magrí Peak oxygen uptake in heart failure: Look behind the number! , 2018, European journal of preventive cardiology.

[9]  P. Ponikowski,et al.  Corrigendum to ‘Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology’ [Eur J Heart Fail 2018;20:3–15] , 2018, European journal of heart failure.

[10]  M. de Antonio,et al.  Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure. , 2018, Journal of the American College of Cardiology.

[11]  R. Arena,et al.  A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid‐range, and preserved ejection fraction , 2018, European journal of heart failure.

[12]  S. Nadar,et al.  What is Heart Failure with Mid-range Ejection Fraction? A New Subgroup of Patients with Heart Failure. , 2018, Cardiac failure review.

[13]  P. Ponikowski,et al.  Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology , 2018, European journal of heart failure.

[14]  G. Parati,et al.  Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long‐term comparison , 2017, European journal of heart failure.

[15]  M. Pfisterer,et al.  Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF) , 2017, European journal of heart failure.

[16]  Roberto Ferrari,et al.  Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.

[17]  G. Fonarow,et al.  Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions. , 2017, JACC. Heart failure.

[18]  Y. Takeishi,et al.  Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction , 2017, European journal of preventive cardiology.

[19]  A. Shah,et al.  Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction , 2017, Journal of the American Heart Association.

[20]  T. Shiroto,et al.  Characterization of heart failure patients with mid‐range left ventricular ejection fraction—a report from the CHART‐2 Study , 2017, European journal of heart failure.

[21]  Gianluigi Savarese,et al.  A comprehensive population‐based characterization of heart failure with mid‐range ejection fraction , 2017, European journal of heart failure.

[22]  D. Mann,et al.  Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid‐range ejection fraction , 2017, European journal of heart failure.

[23]  S. Solomon,et al.  Fussing Over the Middle Child: Heart Failure With Mid-Range Ejection Fraction. , 2017, Circulation.

[24]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[25]  A. Shah,et al.  Heart Failure and Midrange Ejection FractionCLINICAL PERSPECTIVE , 2016 .

[26]  G. Parati,et al.  The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. , 2016, International journal of cardiology.

[27]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[28]  C. Lam,et al.  The middle child in heart failure: heart failure with mid‐range ejection fraction (40–50%) , 2014, European journal of heart failure.

[29]  G. Parati,et al.  Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. , 2013, International journal of cardiology.

[30]  Akshay S. Desai,et al.  Heart failure with recovered ejection fraction: a distinct clinical entity. , 2011, Journal of cardiac failure.

[31]  D. Andreini,et al.  Cardiopulmonary evidence of exercise-induced silent ischaemia , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[32]  M. Lauer,et al.  Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers , 2005, Circulation.

[33]  K. Wasserman,et al.  Exercise Anaerobic Threshold and Ventilatory Efficiency Identify Heart Failure Patients for High Risk of Early Death , 2002, Circulation.

[34]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.